REFERENCES
- Honig G R. Hemoglobin disorders. Nelson Textbook of Pediatrics, ed. 16, R E Behrman, R M Kliegman, B E Jenson. WB Saunders, Philadelphia 2000; 1478–1488
- Weatherall D J, Clegg J B. Inherited haemoglobin disorders: an increasing global health problem. Bull WHO 2001; 79: 704–712, [INFOTRIEVE], [CSA]
- Report of a WHO meeting: Primary Health Care Approaches for Prevention and Control of Congenital and Genetic Disorders, Cairo, Egypt, Dec, 6–81999
- de Silva S, Fisher C A, Premawardhena A, , Sri Lanka Thalassaemia Study Group, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Lancet 2000; 355: 786–791, [INFOTRIEVE], [CSA], [CROSSREF]
- Ho W L, Lin K H, Wang J D, et al. Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan. Bone Marrow Transplant 2006; 37(6)569–574, [INFOTRIEVE], [CSA], [CROSSREF]
- Silvestroni E, Bianco I, Graziani B, et al. Screening of thalassemia carriers in intermediate schools in Latium: results of four years work. J Med Genet 1980; 17: 161–164, [INFOTRIEVE], [CSA]
- Maheshwari M, Arora S, Kabra M, Menon P SN. Carrier screening and prenatal diagnosis of β-thalassemia. Indian Pediatrics 1999; 36: 1119–1125, [INFOTRIEVE], [CSA]
- Cavdar A, Arcasoy A. The incidence of of β-thalassemia and abnormal hemoglobin in Turkey. Acta Haematol 1971; 45: 312–318, [INFOTRIEVE], [CSA]
- Dincol G, Aksoy M, Erdem S. β-Thalassemia with increased HbA2 in Turkey: study in heterozygotes. Hum Hered 1979; 29: 272–278, [INFOTRIEVE], [CSA]
- Canatan D, Bor S, Arcasoy A, Yeįl N. Elbistan yöresinde anormal hemoglobin ve HbA2 yüksekliği ile karakterize beta-thalassemia taşiyici taramasi. [In English: Screening of beta-thalassemia trait characterized with abnormal hemoglobines in Elbistan region.]. Doğa Bilim Dergisi 1990; 14: 555–561, [CSA]
- Kilinç M, Yüreğir G, Tekin N, Ekerbiçer H, Bilaloğlu N. Screening of abnormal hemoglobins in Kahramanmaraş province, 1. National Congress of Haemoglobinopathy, AntalyaTurkey, 1999
- Tunc B, Cetin H, Gumruk F, Istanbullu B, Yavrucuoglu H, Kurt U, Genc H. The prevalence and molecular basis of beta-thalassemia in Isparta province and region. Turk J Pediatr 2002; 44: 18–20, [INFOTRIEVE], [CSA]
- Aydinok Y, Oztop S, Nisli G, Kavakli K. Prevalence of beta-thalassemia trait in 1124 students from Aegean region of Turkey. J Trop Pediatr 1997; 43: 184–185, [INFOTRIEVE], [CSA], [CROSSREF]
- Bircan I, Sisli S, Güven A, et al. Hemoglobinopaties in district of Antalya, Turkey. Pediatr Hematol Oncol 1993; 10: 289–291, [INFOTRIEVE], [CSA]
- Yüreğir G T, Arpaci D A, Aksoy K, et al. Population at risk for hemoglobinopaties in Çukurova, Türkiye: Need for prenatal diagnosis. Ann Med Sci 1995; 14: 61–69, [CSA]
- Ahi S. The Prevalence of Hemoglobinopathy and Thalassemia in Gaziantep Region. Thesis, Gaziantep University, Department of Biochemistry, GaziantepTurkey 1998
- Gurgey A, Beksac S, Gumruk E, et al. Prenatal diagnosis of hemoglobinopathies in Turkey: Hacettepe experience. Pediatr Hematol Oncol 1996; 13: 163–166, [INFOTRIEVE], [CSA]
- Maram E S, Amiri Z M, Haghshenas M. Effectiveness of osmotic fragility screening with varying saline concentration in detecting beta-thalassemia trait. Irn J Med Sci 2000; 25: 56–58, Accessed at http://ijms.sums.ac.ir/0012/setoudehmaram0012.html, [CSA]
- Gomber S, Sanjeev, Madan N. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait. J Trop Pediatr 1997; 43: 363–366, [INFOTRIEVE], [CSA], [CROSSREF]